These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M Front Immunol; 2018; 9():1199. PubMed ID: 29899744 [No Abstract] [Full Text] [Related]
3. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells. Segura M Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626 [TBL] [Abstract][Full Text] [Related]
4. Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways. Calzas C; Goyette-Desjardins G; Lemire P; Gagnon F; Lachance C; Van Calsteren MR; Segura M Infect Immun; 2013 Sep; 81(9):3106-18. PubMed ID: 23774593 [TBL] [Abstract][Full Text] [Related]
5. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Goyette-Desjardins G; Auger JP; Dolbec D; Vinogradov E; Okura M; Takamatsu D; Van Calsteren MR; Gottschalk M; Segura M Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747605 [No Abstract] [Full Text] [Related]
6. Characterization of porcine dendritic cell response to Streptococcus suis. Lecours MP; Segura M; Lachance C; Mussa T; Surprenant C; Montoya M; Gottschalk M Vet Res; 2011 Jun; 42(1):72. PubMed ID: 21635729 [TBL] [Abstract][Full Text] [Related]
7. Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model. Clarke D; Letendre C; Lecours MP; Lemire P; Galbas T; Thibodeau J; Segura M J Immunol Res; 2016; 2016():5290604. PubMed ID: 26989699 [TBL] [Abstract][Full Text] [Related]
8. The Role of Porcine Monocyte Derived Dendritic Cells (MoDC) in the Inflammation Storm Caused by Streptococcus suis Serotype 2 Infection. Liu J; Tian ZY; Xiao YC; Wang XL; Jin ML; Shi DS PLoS One; 2016; 11(3):e0151256. PubMed ID: 26974437 [TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of granulocyte-colony stimulating factor (G-CSF) production by dendritic cells and macrophages during Streptococcus suis infection. Bleuzé M; Auger JP; Lavagna A; Gisch N; Gottschalk M; Segura M Immunobiology; 2020 Jul; 225(4):151979. PubMed ID: 32747024 [TBL] [Abstract][Full Text] [Related]
10. Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals. Calzas C; Lemire P; Auray G; Gerdts V; Gottschalk M; Segura M Infect Immun; 2015 Jan; 83(1):441-53. PubMed ID: 25385801 [TBL] [Abstract][Full Text] [Related]
11. Role of the Streptococcus suis serotype 2 capsular polysaccharide in the interactions with dendritic cells is strain-dependent but remains critical for virulence. Auger JP; Dolbec D; Roy D; Segura M; Gottschalk M PLoS One; 2018; 13(7):e0200453. PubMed ID: 30001363 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival. Meijerink M; Ferrando ML; Lammers G; Taverne N; Smith HE; Wells JM PLoS One; 2012; 7(4):e35849. PubMed ID: 22558240 [TBL] [Abstract][Full Text] [Related]
13. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. Lecours MP; Gottschalk M; Houde M; Lemire P; Fittipaldi N; Segura M J Infect Dis; 2011 Sep; 204(6):919-29. PubMed ID: 21849289 [TBL] [Abstract][Full Text] [Related]
14. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine. Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2. Wang J; Feng Y; Wang C; Zheng F; Hassan B; Zhi L; Li W; Yao Y; He E; Jiang S; Tang J BMC Microbiol; 2017 Mar; 17(1):67. PubMed ID: 28292261 [TBL] [Abstract][Full Text] [Related]
16. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Segura M; Vadeboncoeur N; Gottschalk M Clin Exp Immunol; 2002 Feb; 127(2):243-54. PubMed ID: 11876746 [TBL] [Abstract][Full Text] [Related]
17. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. Domínguez-Punaro MC; Segura M; Plante MM; Lacouture S; Rivest S; Gottschalk M J Immunol; 2007 Aug; 179(3):1842-54. PubMed ID: 17641051 [TBL] [Abstract][Full Text] [Related]
18. Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs. Hsueh KJ; Lee JW; Hou SM; Chen HS; Chang TC; Chu CY Transbound Emerg Dis; 2014 Dec; 61(6):e35-43. PubMed ID: 23489297 [TBL] [Abstract][Full Text] [Related]
19. Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Fittipaldi N; Segura M; Grenier D; Gottschalk M Future Microbiol; 2012 Feb; 7(2):259-79. PubMed ID: 22324994 [TBL] [Abstract][Full Text] [Related]
20. Effect of the glycosyltransferases on the capsular polysaccharide synthesis of Streptococcus suis serotype 2. Zhang Y; Ding D; Liu M; Yang X; Zong B; Wang X; Chen H; Bei W; Tan C Microbiol Res; 2016 Apr; 185():45-54. PubMed ID: 26946377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]